Quebec Makes the Move to Reimburse Large B-Cell Lymphoma Treatment
MONTREAL, Aug. 17, 2023 /CNW/ - Incyte Biosciences Canada is pleased to announce that Quebec has made Minjuvi® (tafasitamab) in combination with lenalidomide accessible with reimbursement under the Régie de...
Read More









